Sameric Bio is a biotech engine
Sameric Bio is a biotech engine. We in-license new biology and catalyze it into new medicines for patients. AI is speeding up discovery, but turning promising science into a medicine is still the hardest part of the journey. That is the part we focus on. We work with world-class scientists and institutions to in-license exceptional biology that already has animal proof of concept. We then drive it quickly toward clinical proof of concept. We focus on multifunctional protein medicines, such as bispecifics, engagers and enzyme-linked proteins, for diseases with high unmet need. Every program runs through DrugBuilder, our AI-native translation ecosystem. It combines AI agents, disease simulations and generative protein design with our own lab in Vienna. What we learn from each program feeds into the next, so the engine gets better with every medicine we develop. Sameric Bio was founded by a team that has built, scaled and sold biotech companies before. We are now building the biotech engine for the medicines of tomorrow. Headquarters: Vienna, Austria sameric.bio Imprint: https://www.sameric.bio/imprint